J. von Stebut

Therapeutic targeting of ATR in alveolar rhabdomyosarcoma

M. Selbach, P. Mertins, K. Haase, 2022, Nature Communications.

Elimusertib outperforms standard of care chemotherapy in preclinical patient-derived pediatric solid tumor models

A. Kühl, K. Haase, J. Schulte, 2022, bioRxiv.

Therapeutic targeting of PGBD5-induced DNA repair dependency in pediatric solid tumors

A. Kentsis, A. Kung, E. de Stanchina, 2017, Science Translational Medicine.

Small-Molecule Dual PLK1 and BRD4 Inhibitors are Active Against Preclinical Models of Pediatric Solid Tumors

Shuai Liu, F. Klironomos, J. Schulte, 2019, Translational oncology.

Exploiting a PAX3-FOXO1-induced synthetic lethal ATR dependency for rhabdomyosarcoma therapy

M. Selbach, K. Haase, Koshi Imami, 2020, bioRxiv.